ArticleCancers2026

Abnormal Sialylation Promotes Chemotherapy Resistance in Bladder Cancer via the PI3K-AKT-mTOR Signaling Pathway.

Junlong Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.